Structural Biology in Cancer Research
The primary aim of integrating structural biology into cancer research is to design and discover novel, effective drugs that can target cancer at the molecular level. By combining structural biology with molecular modeling, researchers can understand how cancer-related biomolecules function and interact, enabling precise drug design. This approach accelerates the development of targeted therapies with higher efficacy and fewer side effects. As a result, a significant portion of structural biology research today is focused on cancer, with many leading scientists dedicating their efforts to unraveling the molecular mechanisms behind the disease to drive innovation in cancer treatment.
Related Conference of Structural Biology in Cancer Research
Structural Biology in Cancer Research Conference Speakers
Recommended Sessions
- 3D Structure Determination
- Advanced Techniques in Structural Biology
- AI & Computational Structural Biology
- Biochemistry and Biophysics
- Computational Approach in Structural Biology
- Drug Designing and Biomarkers
- Hybrid Approaches for Structure Prediction
- Membrane Proteins and Receptors
- Molecular Modelling and Dynamics
- Proteomics and Genomics
- Structural Bioinformatics and Computational Biology
- Structural Biology in Cancer Research
- Structural Virology
- Structural Virology and Infectious Diseases
- Structure-Based Drug Discovery
- Structure-Based Solutions to Global Health Challenges
- Structure-Function Relationships
- The Structural Basis of Disease